𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant human granulocyte–colony-stimulating factor–mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis

✍ Scribed by Martin Körbling; James M. Reuben; Hui Gao; Bang-Ning Lee; David M. Harris; David Cogdell; Sergio A. Giralt; Issa F. Khouri; Rima M. Saliba; Richard E. Champlin; Wei Zhang; Zeev Estrov

Book ID
109143374
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
484 KB
Volume
46
Category
Article
ISSN
0372-1248

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Collection efficiency on the fenwal CS30
Collection efficiency on the fenwal CS3000 when using filgrastim (recombinant methionyl human granulocyte colony-stimulating factor) as a peripheral blood stem cell mobilization agent
✍ L. Bik To; German R. Stemmelin; David N. Haylock; Joanne L. Bayly; Dawn Thorp; C 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB

## Abstract The collection efficiency (CE) of the Fenwal CS3000 in collecting peripheral blood stem cells during post‐chemotherapy recovery phase ranges from 58% to 73%. Recently filgrastim (recombinant methionyl human granulocyte colony‐stimulating factor [G‐CSF]) has also been shown to be effecti

Ifosamide, epirubicin and granulocyte co
Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma
✍ M. Arland; S. Leuner; S. Lange; R. Bartsch; C. Kahl; A. Florschütz; A. Franke; H 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract In general, the mobilization of peripheral blood progenitor cells (PBPC) in multiple myeloma (MM) patients is poor and is achieved in most cases by combined cyclophosphamide and G‐CSF. This study was performed to examine the efficacy of combined ifosfamide/epirubicine and G‐CSF for PBPC